Compare Stocks → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ACEVUOTCMKTS:ACICUOTCMKTS:ARBGUOTCMKTS:IMPXUOTCMKTS:SCCB Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACEVUACE Convergence Acquisition$9.77-0.1%$9.77$9.27▼$10.80N/AN/A2,197 shs800 shsACICUAtlas Crest Investment$0.00$0.00▼$0.00N/AN/AN/A28 shsARBGUAequi Acquisition$10.26$10.26$9.47▼$11.15N/AN/A642 shsN/AIMPXUAEA-Bridges Impact$0.00$0.00▼$0.00N/AN/AN/A7,086 shsSCCBSachem Capital Corp. 7.125% Not$24.91-0.4%$25.04$23.86▼$25.49N/AN/A3,118 shs2,092 shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACEVUACE Convergence Acquisition0.00%0.00%0.00%0.00%0.00%ACICUAtlas Crest Investment0.00%0.00%0.00%0.00%0.00%ARBGUAequi Acquisition0.00%0.00%0.00%0.00%+0.88%IMPXUAEA-Bridges Impact0.00%0.00%0.00%0.00%0.00%SCCBSachem Capital Corp. 7.125% Not-0.36%-0.24%-0.36%-0.44%+1.47%This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industryMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACEVUACE Convergence AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AACICUAtlas Crest InvestmentN/AN/AN/AN/AN/AN/AN/AN/AARBGUAequi AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AIMPXUAEA-Bridges ImpactN/AN/AN/AN/AN/AN/AN/AN/ASCCBSachem Capital Corp. 7.125% NotN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACEVUACE Convergence AcquisitionN/AN/AN/AN/AACICUAtlas Crest InvestmentN/AN/AN/AN/AARBGUAequi AcquisitionN/AN/AN/AN/AIMPXUAEA-Bridges ImpactN/AN/AN/AN/ASCCBSachem Capital Corp. 7.125% NotN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACEVUACE Convergence AcquisitionN/AN/AN/AN/AN/AN/AACICUAtlas Crest InvestmentN/AN/AN/AN/AN/AN/AARBGUAequi AcquisitionN/AN/AN/AN/AN/AN/AIMPXUAEA-Bridges ImpactN/AN/AN/AN/AN/AN/ASCCBSachem Capital Corp. 7.125% NotN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACEVUACE Convergence AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AACICUAtlas Crest InvestmentN/AN/A0.00N/AN/AN/AN/AN/AN/AARBGUAequi AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AIMPXUAEA-Bridges ImpactN/AN/A0.00N/AN/AN/AN/AN/AN/ASCCBSachem Capital Corp. 7.125% NotN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACEVUACE Convergence AcquisitionN/AN/AN/AN/AN/AACICUAtlas Crest InvestmentN/AN/AN/AN/AN/AARBGUAequi AcquisitionN/AN/AN/AN/AN/AIMPXUAEA-Bridges ImpactN/AN/AN/AN/AN/ASCCBSachem Capital Corp. 7.125% NotN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipACEVUACE Convergence AcquisitionN/AACICUAtlas Crest InvestmentN/AARBGUAequi AcquisitionN/AIMPXUAEA-Bridges ImpactN/ASCCBSachem Capital Corp. 7.125% Not2.08%Insider OwnershipCompanyInsider OwnershipACEVUACE Convergence AcquisitionN/AACICUAtlas Crest InvestmentN/AARBGUAequi AcquisitionN/AIMPXUAEA-Bridges ImpactN/ASCCBSachem Capital Corp. 7.125% NotN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableACEVUACE Convergence Acquisition4N/AN/ANot OptionableACICUAtlas Crest Investment147,000N/AN/ANot OptionableARBGUAequi Acquisition2N/AN/ANot OptionableIMPXUAEA-Bridges Impact147,000N/AN/ANot OptionableSCCBSachem Capital Corp. 7.125% Not34N/AN/ANot OptionableACICU, SCCB, ACEVU, IMPXU, and ARBGU HeadlinesSourceHeadlineSachem Capital Corp. 7.125% Not (OTCMKTS:SCCB) Stock Price Passes Below Two Hundred Day Moving Average of $24.98americanbankingnews.com - April 19 at 4:24 AMSachem Capital Corp. 7.125% Notes due 2024 (SCCB)nasdaq.com - January 29 at 12:09 AMMedia Sentiment Over TimeCompany DescriptionsACE Convergence AcquisitionOTCMKTS:ACEVUACE Convergence Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on businesses in the IT infrastructure software and semiconductor sectors. ACE Convergence Acquisition Corp. was incorporated in 2020 and is based in Wilmington, Delaware.Atlas Crest InvestmentOTCMKTS:ACICUAequi AcquisitionOTCMKTS:ARBGUAequi Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Aequi Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.AEA-Bridges ImpactOTCMKTS:IMPXUSachem Capital Corp. 7.125% NotOTCMKTS:SCCBsince 2010, sachem capital has been financing opportunistic real estate transactions in the new england area. sachem capital provides quick, short-term bridge capital for real estate investors, builders or developers who need immediate funding or to solve an immediate problem. our creative real estate financing solutions are developed exclusively for those seeking alternatives to conventional bank loans. the executive team has extensive experience in real estate acquisitions, investments, management and development. our hands-on managers have the expertise to quickly assess complex opportunities and non-conventional situations to deliver a closing product that is efficient and opportunistic to our borrowers, and profitable to our shareholders. sachem capital was listed on the nyse on february 10, 2017. the company was designed to address the constant volatility and instability in today's financial markets. we are exited to share with you this extraordinary opportunity to seize favorabl Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.